You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mFOLFOXIRI

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI plus Bevacizumab
  • mFOLFOX6 Plus Bevacizumab
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022

Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Jun 17, 2022

Colorectal Cancer Trial in Wenzhou (mFOLFOXIRI, mFOLFOX6 OR CapeOx)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI
  • mFOLFOX6 OR CapeOx
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Jan 18, 2022

Cholangiocarcinoma Trial in Khon Kaen (mFOLFOXIRI)

Recruiting
  • Cholangiocarcinoma
  • mFOLFOXIRI
  • Khon Kaen, Thailand
    Jarin Chindaprasirt
Aug 31, 2021

Colorectal Carcinoma, Liver Metastases Trial in Shanghai (mFOLFOXIRI regimen, mFOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Carcinoma
  • Liver Metastases
  • mFOLFOXIRI regimen
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Sep 22, 2021

Metastatic Colorectal Cancer Trial in Italy (Panitumumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
  • +3 more
Oct 5, 2021

Locally Advanced Rectal Cancer Trial in Hangzhou (mFOLFOXIRI, Chemoradiotherapy)

Recruiting
  • Locally Advanced Rectal Cancer
  • mFOLFOXIRI
  • Chemoradiotherapy
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Mar 21, 2021

Rectal Cancer Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Rectal Cancer
  • Neoadjuvant chemotherapy with mFOLFOXIRI plus bevacizumab
  • +5 more
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Sep 2, 2020

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI adjuvant chemo, mFOLFOX6 adjuvant chemo)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI adjuvant chemotherapy
  • mFOLFOX6 adjuvant chemotherapy
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Apr 7, 2020

Locally Advanced Rectal Cancer Trial in Hangzhou (mFOLFOXIRI)

Unknown status
  • Locally Advanced Rectal Cancer
  • mFOLFOXIRI
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Nov 18, 2019

Colorectal Tumors, Colorectal Cancer, Colorectal Cancer Metastatic Trial in Guangzhou (Preoperative systematic therapy,

Not yet recruiting
  • Colorectal Neoplasms
  • +8 more
  • Preoperative systematic therapy
  • +2 more
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital of Sun Yat-sen University
Apr 28, 2022

Rectal Cancer, Chemo Effect Trial (Chemoradiation, FOLFOXIRI Protocol, Folfox Protocol)

Not yet recruiting
  • Rectal Cancer
  • Chemotherapy Effect
  • Chemoradiation
  • +2 more
  • (no location specified)
Jun 2, 2019

Colon Cancer Stage II, Colon Cancer Stage III Trial in Guangzhou (neoadjuvant chemoI, Colectomy, adjuvant chemo)

Recruiting
  • Colon Cancer Stage II
  • Colon Cancer Stage III
  • neoadjuvant chemotherapyI
  • +2 more
  • Guangzhou, Guangdong, China
    651 Dongfeng Road East
Jan 14, 2022

Colorectal Cancer Trial in Tainan (bevacizumab, Oxaliplatin, Irinotecan)

Unknown status
  • Colorectal Cancer
  • Tainan, Taiwan
    National Cheng-Kung University Hospital
Mar 12, 2019